MORGAN LONDENBERG: Open Payments
NPI 1174137475 · TOMBALL, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,575 in 100 payments from 25 companies in 2025. Trend: 2023 $897 · 2024 $1,016 · 2025 $1,575
Food & beverage: $1,575
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 19 | $271 |
| ABBVIE INC. | 23 | $256 |
| Novo Nordisk Inc | 11 | $168 |
| GlaxoSmithKline, LLC. | 7 | $124 |
| PFIZER INC. | 5 | $121 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $95 |
| Astellas Pharma US Inc | 3 | $71 |
| ABIOMED | 3 | $52 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $46 |
| Inspire Medical Systems, Inc. | 1 | $37 |
Products named: KRYSTEXXA, QULIPTA, TRELEGY ELLIPTA, Wegovy, VRAYLAR, NURTEC ODT, Kerendia, Veozah.
Industry payments across TX — which companies pay providers there.
